A non-toxic recombinant Clostridium septicum a toxin induces protective immunity in mice and rabbits

被引:0
|
作者
Du, Jige [1 ]
Meki, Irene [2 ]
Li, Qianlin [1 ]
Liu, Ying [1 ]
Zhu, Zhen [1 ]
Pan, Chenfan [1 ]
Xia, Yingju [1 ]
Fu, Lizhi [3 ]
Yang, Liu [3 ]
Zhang, Suhui [3 ]
Yin, Chunsheng [1 ]
Luo, Yufeng [1 ]
Wang, Tuanjie [1 ]
Liu, Bo [1 ,2 ]
Chen, Xiaoyun [1 ]
机构
[1] China Inst Vet Drug Control, Beijing, Peoples R China
[2] IAEA, Vienna, Austria
[3] Chongqing Acad Anim Sci, Chongqing 402460, Peoples R China
关键词
Clostridium septicum alpha toxin; Recombinant expression; Non-toxic; Antigenicity Braxy; PERFRINGENS EPSILON-TOXIN; ALPHA-TOXIN; MUTANT; IDENTIFICATION; SIMILARITY; TURKEYS; VACCINE; DOMAIN; BETA;
D O I
10.1016/j.toxicon.2023.107234
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Clostridium septicum alpha toxin (CSA) plays significant roles in ruminant's braxy. Genetically engineered CSA has been shown to function as a potential vaccine candidate in the prevention of the disease caused by Clostridium septicum. In the present study, we synthesized a non-toxic recombinant, rCSA(m4/TMD) by introducing four amino acid substitutions (C86L/N296A/H301A/W342A) and 11-amino-acid deletion (residues 212 to 222). Compared to recombinant CSA, rCSA(m4/TMD) showed no cytotoxicity to MDCK cells and was not fatal to mice. Moreover, rCSA(m4/TMD) could protect immunized mice against 5 x mouse LD100 (100% lethal dose) of crude CSA without obvious pathological change. Most importantly, rabbits immunized with rCSA(m4/TMD) produced high titers of neutralizing antibodies which protected the rabbits against crude CSA challenge. These data suggest that genetically detoxified rCSA(m4/TMD) is a potential subunit vaccine candidate against braxy.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Intranasal immunization with recombinant Ascaris suum 14-kilodalton antigen coupled with cholera toxin B subunit induces protective immunity to A-suum infection in mice
    Tsuji, N
    Suzuki, K
    Kasuga-Aoki, H
    Matsumoto, Y
    Arakawa, T
    Ishiwata, K
    Isobe, T
    INFECTION AND IMMUNITY, 2001, 69 (12) : 7285 - 7292
  • [42] Fast, non-toxic, and inexpensive n-butanol preparation of recombinant plasmids
    Brieger, J
    Weidt, EJ
    Decker, J
    GENETICS AND MOLECULAR BIOLOGY, 2000, 23 (02) : 299 - 300
  • [43] Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection
    Narita, Kouji
    Hu, Dong-Liang
    Asano, Krisana
    Nakane, Akio
    PATHOGENS AND DISEASE, 2015, 73 (04):
  • [44] Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis
    Rhie, GE
    Park, YM
    Han, JS
    Yu, JY
    Seong, WK
    Oh, HB
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2005, 45 (02): : 341 - 347
  • [45] Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity
    Ciarlet, M
    Crawford, SE
    Barone, C
    Bertolotti-Ciarlet, A
    Ramig, RF
    Estes, MK
    Conner, ME
    JOURNAL OF VIROLOGY, 1998, 72 (11) : 9233 - 9246
  • [46] STRUCTURE-ACTIVITY-RELATIONSHIPS IN DIPHTHERIA-TOXIN - STUDY OF A NON-TOXIC FORM OF TOXIN, CRM 228
    DELAUNOY, JP
    ZANEN, J
    ARCHIVES INTERNATIONALES DE PHYSIOLOGIE DE BIOCHIMIE ET DE BIOPHYSIQUE, 1981, 89 (02): : B54 - B54
  • [47] The Anti-diarrheal Activity of the Non-toxic Dihuang Powder in Mice
    Shang, Xiaofei
    Miao, Xiaolou
    Yang, Feng
    Li, Bing
    Guo, Xiao
    Pan, Hu
    Zhang, Yu
    Zhang, Jiyu
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [48] ANTI-TOXIC CHOLERA IMMUNITY IN MICE - INFLUENCE OF ANTIGEN DEPOSITION ON ANTI-TOXIN-CONTAINING CELLS AND PROTECTIVE IMMUNITY IN DIFFERENT PARTS OF THE INTESTINE
    LANGE, S
    NYGREN, H
    SVENNERHOLM, AM
    HOLMGREN, J
    INFECTION AND IMMUNITY, 1980, 28 (01) : 17 - 23
  • [50] A non-toxic recombinant protein rSUMO-CPBm4 as a potential vaccine candidate against Clostridium perfringens type C beta enterotoxemia
    Gao, Y.
    Du, J. G.
    Jirapattharasate, C.
    Galon, E.
    Ji, S. W.
    Ran, Z. G.
    Xia, Y. Q.
    TROPICAL BIOMEDICINE, 2023, 40 (04) : 400 - 405